ClinicalTrials.Veeva

Menu
M

My Preferred Research | Miami, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Atogepant
Metformin
Sugar
Linaclotide
Sodium
Glucose
Dupilumab
Ubrogepant
Tiotropium

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 14 total trials

A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or Both (AMBITION4)

The study is testing zenagamtide in participants with type 2 diabetes. The purpose of this clinical study is to find out if zenagamtide is safe and e...

Not yet enrolling
Diabetes Mellitus, Type 2
Drug: Placebo semaglutide
Drug: Semaglutide

The study is testing zenagamtide in participants with type 2 diabetes and chronic kidney disease. The purpose of this clinical study is to find out i...

Not yet enrolling
Chronic Kidney Disease
Type 2 Diabetes
Other: Placebo
Drug: Zenagamtide

This study is being done to look at how well zenagamtide lowers blood sugar levels and body weight in people with type 2 diabetes when compared to pl...

Not yet enrolling
Diabetes Mellitus, Type 2
Drug: Placebo
Drug: Zenagamtide

Migraine is a disease that most often causes moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompa...

Enrolling
Chronic Migraine
Drug: Atogepant
Drug: Placebo for Atogepant

A migraine is a moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vo...

Enrolling
Episodic Migraine
Drug: Placebo-Matching Atogepant
Drug: Atogepant

The purpose of this clinical study is to find out if zenagamtide is safe and effective for treating people who have type 2 diabetes. There are 2 stud...

Not yet enrolling
Type 2 Diabetes
Drug: Zenagamtide
Drug: Placebo

A migraine is a moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vo...

Invitation-only
Migraine Prophylaxis
Drug: Atogepant

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea...

Invitation-only
Migraine
Drug: Ubrogepant

This is an interventional, randomized, parallel group, treatment, Phase 3b/4, double blind, 2-arm study to assess the effect of dupilumab compared to...

Active, not recruiting
Asthma
Drug: Placebo
Drug: Dupilumab

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea...

Enrolling
Migraine
Drug: Placebo-Matching Ubrogepant
Drug: Ubrogepant

Trial sponsors

AbbVie logo
Novo Nordisk logo
Sanofi logo
X

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems